Company Can-Fite BioPharma Ltd. Nyse

CANF

US13471N1028

Pharmaceuticals

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Ratings for Can-Fite BioPharma Ltd.

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Biopharmaceuticals

End-of-day quote Nyse Other stock markets 23:00:00 04/02/2024 GMT			5-day change	1st Jan Change
2.02 ^USD	-3.35%		-4.04%	-8.18%

06-10	Can-Fite Biopharma Ltd. Receives IRB Approval for the Treatment of Pancreatic Cancer with Namodenoson in a Phase IIa Study	CI
06-06	Transcript : Can-Fite BioPharma Ltd. - Special Call

Can Fite Biofarma Ltd is an Israel-based clinical-stage biopharmaceutical company engaged in developing orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The Company co-develop formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. It's technology utilizes the Gi protein associated A3AR as a therapeutic target. A3AR is expressed in inflammatory and cancer cells, and not significantly expressed in normal cells, suggesting that the receptor could be a target for pharmacological intervention.

ILS in Million	2022	Weight	2023	Weight	Delta
Biopharmaceuticals 100.0 %	3	100.0 %	3	100.0 %	+0.69%

ILS in Million	2022	Weight	2023	Weight	Delta
Israel 100.0 %	3	100.0 %	3	100.0 %	+0.69%

Managers	Title	Age	Since
Motti Farbstein CEO	Chief Executive Officer	59	31/07/03
Pnina Fishman FOU	Founder	74	10/09/94
Ilan Cohn FOU	Founder	68	10/09/94
Zivit Harpaz CTO	Chief Tech/Sci/R&D Officer	-	-
Michael Silverman CTO	Chief Tech/Sci/R&D Officer	-	-
Sari Fishman PRN	Corporate Officer/Principal	52	31/12/03
William D. Kerns PRN	Corporate Officer/Principal	-	-

Members of the board	Title	Age	Since
Abraham Sartani BRD	Director/Board Member	76	31/12/00
Ilan Cohn FOU	Founder	68	10/09/94
Pnina Fishman FOU	Founder	74	10/09/94
Yaacov Goldman BRD	Director/Board Member	68	31/07/17
Guy Regev BRD	Director/Board Member	55	30/06/11
Yossi Bornstein BRD	Director/Board Member	66	04/08/21

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	1,497,128,493	1,496,706,120 ( 99.97 %)	0	99.97 %

Name	Equities	%	Valuation
IBI Mutual Funds Management (1978) Ltd. 0.1477 %	2,210,774	0.1477 %	16 117 $
Alumot Sprint Mutual Funds Management Ltd. 0.0730 %	1,092,174	0.0730 %	7 962 $
Pnina Fishman 0.0176 %	263,433	0.0176 %	1 920 $
Ilan Cohn 0.008922 %	133,567	0.008922 %	974 $
Guy Regev 0.001619 %	24,240	0.001619 %	177 $
Motti Farbstein 0.000076 %	1,133	0.000076 %	8 $
Yossi Bornstein 0.000000 %	0	0.000000 %	- $
Sari Fishman 0.000000 %	0	0.000000 %	- $
Yaacov Goldman 0.000000 %	0	0.000000 %	- $
Abraham Sartani 0.000000 %	0	0.000000 %	- $

Name	Equities	%	Valuation
Armistice Capital LLC 7.671 %	382,798	7.671 %	903 403 $
Morgan Stanley Capital Services LLC 1.118 %	55,807	1.118 %	131 705 $
RhumbLine Advisers LP 0.3703 %	18,482	0.3703 %	43 618 $
Citadel Securities GP LLC 0.2840 %	14,171	0.2840 %	33 444 $
FIFTH THIRD BANCORP 0.0601 %	3,000	0.0601 %	7 080 $
UBS Securities LLC 0.0435 %	2,172	0.0435 %	5 126 $
National Bank Financial, Inc. 0.0120 %	600	0.0120 %	1 416 $
Citigroup Global Markets, Inc. (Investment Management) 0.0111 %	553	0.0111 %	1 305 $

Can-Fite BioPharma Ltd.

26 Ben Gurion Street

5257346, Ramat Gan

+972 3 924 1114

http://www.canfite.com

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

0.04

Average target price

Consensus

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Biopharmaceuticals

	1st Jan change	Capi.
CSL LIMITED	+0.75%	92.38B
SAMSUNG BIOLOGICS CO.,LTD.	-3.03%	37.9B
BIOGEN INC.	-10.46%	33.73B
UCB	+73.45%	27.98B
BIOMARIN PHARMACEUTICAL INC.	-13.39%	15.86B
INCYTE CORPORATION	-1.08%	13.97B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-11.15%	11.67B
ALTEOGEN INC.	+169.04%	10.17B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-50.19%	10.04B

Biopharmaceuticals